Effective treatment and prevention of a varicose illness and hemorrhoids on the basis of discovery of the Nobel laureate Albert Sent-Dyerdi (USA) – a diosmina of a bioflavonoid.

From 40 to 60% of inhabitants of the globe have signs of the chronic venous insufficiency (CVI). Along with other methods of treatment, on any of stages of HVN the pharmacotherapy is necessary. Venomotor medicine, or fleboprotectors of systematic action on the basis of the micronized diosmin are the most effective (this substance is received from a peel of a citrus). The main property of a diosmin is normalization of vessels walls permeability and increase of their tone, that allows to achieve progress in therapy of the diseases caused by HVN, in particular, of a varicosity, fragilities of capillaries, sharp and chronic hemorrhoids, chronic venous insufficiency.

Flavovein is the first drug of a diosmin in capsules on the market of the CIS countries. Such form of release (unlike traditional tablets) provides high bioavailability, the maximum accuracy of a dosage, the best safety.

Flavovein normalizes a tone of venous vessels, improves microcirculation and lymphatic outflow, normalizes functions of endothelium and permeability of walls of vessels, it has the anesthetizing and anti-inflammatory effect. In treatment of sharp hemorrhoids Flavovein is applied to eliminate bleeding, reduce pain and an inflammation, increase the efficiency of low-invasive and expeditious treatment.

Read more about FLAVOVEIN